 |
 |
Hi all, A PDF appointment is available in the Lemieux lab in the Department of Biochemistry, Faculty of Medicine and Dentistry at the University of Alberta. The successful applicant will conduct research on drug development targeting immune checkpoint proteins. This work will be conducted with a strong multidisciplinary team at the University of Alberta. This position is funded by the Alberta Cancer Foundation and is available immediately. - Candidate should have a Ph.D. in biochemistry or molecular biology. - Experience in protein purification, ligand: protein interaction methods (isothermal titration calorimetry) and structural biology (PX or NMR) is desired. - Experience with microscale thermophoresis, SPR, and thermal shift assays would be an added benefit. Successful candidate should be able to conduct research independently, analyze and interpret data, and write journal articles, as well as should be able to work in a large research group and assist/mentor graduate students. *To Apply: * Send your CV, research statement, and list of three referees to: [log in to unmask] ********************************** M. Joanne Lemieux, Ph.D. Associate Professor, Associate Director Membrane Protein Disease Research Group, Alberta Innovates Health Solutions Scholar Department of Biochemistry, Faculty of Medicine & Dentistry, University of Alberta Medical Sciences Bldg. Office 4-53 Lab 4-51 University of Alberta Edmonton AB, T6G 2H7 office phone: 780-492-3586 lab phone: 780-492-3465 fax: 780-492-0886 International Proteolysis Society Meeting - 2017 http://www.ips2017.org Lab web pages: http://www2.biochem.ualberta.ca/LemieuxLab http://www.biochem.ualberta.ca/faculty_detail.php?id=39# Membrane Protein Disease Research Group: http://www.mprg.med.ualberta.ca/index.php NSERC Membrane Training Group: www.MembraneTraining.ualberta.ca CONFIDENTIALITY WARNING This communication is intended for the use of the recipient to which it is addressed, and may contain confidential, personal, and/or privileged information. Please contact me immediately if you are not the intended recipient of this communication, and do not copy, distribute, or take action relying on it. Any communication received in error, or subsequent reply, should be deleted or destroyed.